Literature DB >> 2579816

Positive 57Co-bleomycin scintigraphy in silent mediastinal metastases of malignant melanoma.

R A Valdés Olmos, J H van der Bergh, J F den Hamer, H J Serdijn.   

Abstract

A case with an intense accumulation of 57Co-bleomycin in lymph node metastases of malignant melanoma in the mediastinum as a casual finding is reported. The patient had undergone a 57Co-bleomycin scintigraphy because of a peripheral lesion on the chest X-ray, in which a pathological diagnosis was impossible to obtain. This lesion showed no uptake of the radiopharmaceutical.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 2579816     DOI： 10.1007/bf00261772

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN： 0340-6997


  10 in total

1.  Gallium-67 scintigraphy in malignant melanoma.

Authors:  M S Milder; R S Frankel; G B Bulkley; A S Ketcham; G S Johnston
Journal:  Cancer       Date:  1973-12       Impact factor: 6.860

2.  Visualizing human malignant melanoma and metastases. Use of chloroquine analog tagged with iodine 125.

Authors:  W H Beierwaltes; L M Lieberman; V M Varma; R E Counsell
Journal:  JAMA       Date:  1968-09-30       Impact factor: 56.272

3.  Some experience with 57Co-labeled bleomycin as a tumor-seeking agent.

Authors:  J J Rasker; A M Poll; H Beekhuis; M G Woldring; H O Nieweg
Journal:  J Nucl Med       Date:  1975-11       Impact factor: 10.057

4.  Iodinated bleomycin: an unsatisfactory radiopharmaceutical for tumor localization.

Authors:  W C Eckelman; H Kubota; B A Siegel; T Komai; W J Rzeszotarski; R C Reba
Journal:  J Nucl Med       Date:  1976-05       Impact factor: 10.057

5.  Radiation absorbed doses from Co-57- and Co-55 bleomycin.

Authors:  H Beekhuis; O E Nieweg
Journal:  J Nucl Med       Date:  1984-04       Impact factor: 10.057

6.  Gallium-67 scintigraphy in multisystem malignant melanoma.

Authors:  F I Jackson; T A McPherson; B C Lentle
Journal:  Radiology       Date:  1977-01       Impact factor: 11.105

7.  Clinical evaluation of radiolabeled bleomycin (BLEO) for tumor detection.

Authors:  R B Grove; R C Reba; W C Eckelman; M Goodyear
Journal:  J Nucl Med       Date:  1974-06       Impact factor: 10.057

8.  Stability of 111In-bleomycin in vivo--properties compared with 57Co-bleomycin.

Authors:  D Y Hou; H Hoch; G S Johnston; K C Tsou; R J Farkas; E E Miller
Journal:  Eur J Nucl Med       Date:  1983

9.  A clinical evaluation of indium-111 bleomycin as a tumor-imaging agent.

Authors:  D L Lilien; S E Jones; R E O'Mara; S E Salmon; B G Durie
Journal:  Cancer       Date:  1975-04       Impact factor: 6.860

10.  57Co-bleomycin and 67Ga-citrate in detecting and staging lung cancer.

Authors:  O E Nieweg; H Beekhuis; D A Piers; H J Sluiter; A M van der Wal; M G Woldring
Journal:  Thorax       Date:  1983-01       Impact factor: 9.139
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.